BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34424323)

  • 1. B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations.
    Six KA; Gerdemann U; Brown AL; Place AE; Cantor AB; Kutny MA; Avagyan S
    Blood Adv; 2021 Aug; 5(16):3199-3202. PubMed ID: 34424323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition.
    Avagyan S; Brown AL
    J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Familial leukemia due to germline RUNX1 mutations: lessons learned from two decades of research and unsolved problems].
    Osato M; Nambu A
    Rinsho Ketsueki; 2020; 61(6):687-696. PubMed ID: 32624544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations.
    Toratani K; Watanabe M; Kanda J; Oka T; Hyuga M; Arai Y; Iwasaki M; Sakurada M; Nannya Y; Ogawa S; Yamada T; Takaori-Kondo A
    Int J Hematol; 2023 Sep; 118(3):400-405. PubMed ID: 36897502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new form of familial platelet disorder caused by germline mutations in RUNX1 in a pedigree].
    Guan J; Wang LL; Wang CY; Zhu XM; Shuai HZ; Yi X; Zou L; Yu D; Cheng H
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):393-400. PubMed ID: 37032134
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
    Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
    J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.
    Cavalcante de Andrade Silva M; Krepischi ACV; Kulikowski LD; Zanardo EA; Nardinelli L; Leal AM; Costa SS; Muto NH; Rocha V; Velloso EDRP
    Cancer Genet; 2018 Apr; 222-223():32-37. PubMed ID: 29666006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive phenotypes in two children with novel germline
    Bagla S; Regling KA; Wakeling EN; Gadgeel M; Buck S; Zaidi AU; Flore LA; Chicka M; Schiffer CA; Chitlur MB; Ravindranath Y
    Pediatr Hematol Oncol; 2021 Feb; 38(1):65-79. PubMed ID: 32990483
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression.
    Cabrerizo Granados D; Barbosa I; Baliakas P; Hellström-Lindberg E; Lundin V
    Genes Chromosomes Cancer; 2023 Nov; 62(11):672-677. PubMed ID: 37303296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.
    Yokota A; Huo L; Lan F; Wu J; Huang G
    Mol Cells; 2020 Feb; 43(2):145-152. PubMed ID: 31964134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
    Schlegelberger B; Heller PG
    Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
    Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
    Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.
    Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
    Blood Adv; 2024 Jan; 8(2):497-511. PubMed ID: 38019014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.
    Simon L; Spinella JF; Yao CY; Lavallée VP; Boivin I; Boucher G; Audemard E; Bordeleau ME; Lemieux S; Hébert J; Sauvageau G
    Blood; 2020 May; 135(21):1882-1886. PubMed ID: 32315381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
    Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
    Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.
    Kundu M; Compton S; Garrett-Beal L; Stacy T; Starost MF; Eckhaus M; Speck NA; Liu PP
    Blood; 2005 Nov; 106(10):3621-4. PubMed ID: 16051740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
    Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
    [No Abstract]   [Full Text] [Related]  

  • 18. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
    Preudhomme C; Renneville A; Bourdon V; Philippe N; Roche-Lestienne C; Boissel N; Dhedin N; André JM; Cornillet-Lefebvre P; Baruchel A; Mozziconacci MJ; Sobol H
    Blood; 2009 May; 113(22):5583-7. PubMed ID: 19357396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
    Bluteau D; Gilles L; Hilpert M; Antony-Debré I; James C; Debili N; Camara-Clayette V; Wagner-Ballon O; Cordette-Lagarde V; Robert T; Ripoche H; Gonin P; Swierczek S; Prchal J; Vainchenker W; Favier R; Raslova H
    Blood; 2011 Dec; 118(24):6310-20. PubMed ID: 21725049
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.